Soy and vegetable oil bio-printing inks
Formulation of lithographic offset, sheetfed, and newsprint inks using refined soybean oil and vegetable fatty acid esters replacing 100% of petroleum-derived mineral distillates, slashing VOC emissions and improving paper de-inking recyclability.
1 · What it gives
Soy and vegetable oil bio-printing inks represents a critical node in high-value fine chemical and active pharmaceutical ingredient (API) biomanufacturing, overcoming the thermodynamic limits, toxic waste streams, and low stereoselectivity associated with legacy multi-step organometallic synthesis. Through targeted chemoenzymatic cascades, stereospecific biotransformations, and recombinant fermentation, complex chiral centers, heterocyclic scaffolds, and delicate functional intermediates are constructed under ambient conditions with near-perfect atom economy.
The technological platform integrates continuous microreactor flow biocatalysis, counter-current liquid-liquid centrifugal extraction, preparative simulated moving bed (SMB) chromatography, and agitated Nutsche filter drying (ANFD). Advanced chemical engineering systems achieve overall isolated yields exceeding 85% with optical and chemical purities surpassing 99.8%. Operations adhere strictly to ICH Q7 cGMP guidelines, ensuring mutagenic impurities and heavy metal residues remain well below 0.05% thresholds in full compliance with global pharmacopeias.
The key directions of this technology are:
- Chemoenzymatic Route Engineering in Soy and vegetable oil bio-printing inks: Interlocking synthetic organic chemistry with stereospecific biocatalytic steps (ketoreductases, transaminases) to truncate synthetic routes by up to 60%.
- Continuous Flow Microreactor Chemistry: Transitioning batch syntheses to microchannel flow reactors with immobilized enzyme monoliths, eliminating hazardous intermediate accumulation.
- Rigorous Impurity Profiling & Genotoxic Control: Deploying high-resolution Orbitrap LC-MS to map and purge trace mutagenic byproducts below ICH Q3A/B limits (<0.05%).
- Polymorph-Controlled cGMP Crystallization: Utilizing continuous oscillatory baffled crystallizers with inline FBRM monitoring to lock in stable therapeutic crystal polymorphs.
Sectoral value chain#
┌────────────────────────────────────────────────────────┐
│ Tier 1: Chiral Precursor Activation & Sourcing │
│ (Starting materials cGMP assay & pre-activation) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 2: Chemoenzymatic Continuous Flow Reactor │
│ (Immobilized enzyme microchannel with cofactor recycle│
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 3: Counter-Current Centrifugal Extraction │
│ (Multi-stage liquid-liquid organic solvent partition) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 4: Preparative Chiral SMB Chromatography │
│ (Simulated moving bed resolving optical antipodes) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 5: ANFD Controlled Crystallization & Drying │
│ (Enclosed Nutsche filter drying & jet micronization) │
└────────────────────────────────────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Starting Material Activation | Synthesis, incoming compendial quality control, and dissolution of pro-chiral key starting materials (KSM). | In: Commercial fine chemicals, solvents, activation reagents. Out: Sterile, analytical-grade pro-chiral feed solution (>98.5% purity). |
| Continuous Flow Transformation | Stereospecific biotransformation in jacketed microchannel reactors containing engineered biocatalysts. | In: Pro-chiral substrate, immobilized enzymes, recycled NADPH. Out: High-conversion reaction stream (>99.0% conversion, ee >99.8%). |
| Liquid-Liquid Centrifugal Extraction | Counter-current multi-stage centrifugal extraction separating organic active from aqueous enzyme waste. | In: Reaction effluent, pharmaceutical ethyl acetate/heptane. Out: Concentrated organic product extract (spent enzymes separated). |
| Preparative SMB Chromatography | Continuous simulated moving bed chromatography on chiral stationary phases to purge trace enantiomers. | In: Organic extract, mobile phase solvents. Out: Chromatographically pure API stream (all impurities <0.10%). |
| Polymorph Crystallization & Drying | Controlled cooling crystallization, enclosed agitated Nutsche filter drying (ANFD), and jet milling. | In: Purified stream, seed crystals, pharmaceutical nitrogen. Out: Compendial-grade micronized cGMP API (>99.8% purity, Form I). |
Cross-cutting technologies of the sector:
- Enclosed Agitated Nutsche Filter Dryers (ANFD): Contained pressure filtration, multi-solvent displacement washing, and vacuum drying in a single cGMP vessel.
- Focused Beam Reflectance Measurement (FBRM): Inline laser chord length tracking in crystallization slurries to monitor nucleation and growth kinetics in real time.
2 · What it replaces 6 · matched by industry
3 · How to implement 5 steps
- 1Alkyd bio-vehicle cookingprocessingCooking refined soybean oil, pentaerythritol, and phthalic anhydride at 220–240°C in inert nitrogen atmosphere to polymerize clear alkyd varnish vehicles.Who can do this step matched automaticallyAdami Sa Global✓ ISO 9001 industrial scale“Industrial supplier for Soy and vegetable oil bio-printing inks”
- 2Resin dissolution and wax blendingprocessingDissolving rosin-modified phenolic resins into soy oil vehicles, blending bio-based carnauba and amide slip waxes at 160°C.Who can do this step matched automaticallyAdami Sa Global✓ ISO 9001 industrial scale“Industrial supplier for Soy and vegetable oil bio-printing inks”
- 3High-shear pigment pre-dispersionprocessingPremixing organic azo/phthalocyanine dry pigment powders into warm soy varnish using high-torque dual-shaft dispersers.Who can do this step matched automaticallyAdami Sa Global✓ ISO 9001 industrial scale“Industrial supplier for Soy and vegetable oil bio-printing inks”
- 4Three-roll mill nano-dispersion grindingprocessingPassing ink paste through hydraulic cooled three-roll grinding mills to reduce pigment agglomerates below 2 microns.Who can do this step matched automaticallyAdami Sa Global✓ ISO 9001 industrial scale“Industrial supplier for Soy and vegetable oil bio-printing inks”
- 5Tack standardisation and rotary packagingprocessingAdjusting ink rheological viscosity and tack (9–13 units) with soy fatty acid methyl esters, packaging in vacuum tins and metal drums.Who can do this step matched automaticallyAdami Sa Global✓ ISO 9001 industrial scale“Industrial supplier for Soy and vegetable oil bio-printing inks”
4 · Who delivers
Matched suppliers (matched automatically)
| Pili | France | Producer | active |
| Golden Oil Industries Limited | Nigeria | Producer | active |
| NatureWorks | United States | Producer | active |
| Spiga Nord S.p.A. | Italy | Producer | active |
| Ecogreen Oleochemicals | Indonesia | Producer | active |
| REWOW S.r.l. | Italy | Producer | active |
| LGMC - Mutandis | Morocco | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Novonesis (Novozymes) | 🇩🇰 Denmark | Industrial Enzyme Platforms & Microbial Solutions | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Codexis | 🇺🇸 United States | CodeEvolver Directed Evolution & API Biocatalysts | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| BASF | 🇩🇪 Germany | Integrated Chemical & Biocatalytic Synthesis | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Enzymaster | 🇨🇳 China | Engineered Biocatalysts & Chiral Fine Chemicals | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Lonza | 🇨🇭 Switzerland | Microbial CDMO & Custom Biocatalysis Platforms | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Evonik Industries | 🇩🇪 Germany | Fermentation Biosurfactants & Specialty Intermediates | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
5 · Rules & route to market
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
FDA CDER cGMP compliance, Type II Drug Master File (DMF), BARDA critical onshoring#
- FDA 21 CFR Part 210/211 cGMP Compliance: Comprehensive operational validation and quality assurance for active pharmaceutical manufacturing of Soy and vegetable oil bio-printing inks.
- Type II Drug Master File (DMF) Submission: Full chemistry, manufacturing, and controls (CMC) documentation supported by ICH stability data.
- BARDA Critical Pharmaceutical Onshoring: Federal strategic support targeting domestic continuous-flow manufacturing of essential medical ingredients.
European Union
EMA Active Substance Master File (ASMF), EDQM CEP certification, Critical Medicines Alliance#
- EMA & EDQM CEP Certification: Issuance of Certificates of Suitability demonstrating adherence to European Pharmacopoeia (Ph. Eur.) standards.
- EU Critical Medicines Alliance Support: Strategic public investments to de-risk green biocatalytic synthesis routes for essential medicines.
- ECHA REACH & Industrial Emissions Directive (IED): Strict solvent recovery mandates and volatile organic compound (VOC) emissions abatement.
China
14th Five-Year Bioeconomy Strategy, National Medical Products Administration (NMPA) GMP, ChP 2025#
- Green Pharmaceutical Manufacturing Priority: Strategic industrialization of 大豆油基环保胶印与包装印刷油墨 within API hubs across Zhejiang, Jiangsu, and Shandong.
- NMPA Drug Platform Registration & Audits: Mandatory registration on the National Drug Intermediate Platform and dynamic cGMP on-site inspections.
- Chinese Pharmacopoeia (ChP) Compliance: Rigorous control of related substances, genotoxic impurities, and residual solvents under compendial monographs.
6 · Money: tenders & grants
| Grant | Advancing bio-printing of living cells for regenerative medicine European Commission · EU | Sep 22, 2027 303 days |
| Grant | Improving analytical capacity for sustainable competitiveness of the agricultural sector European Commission · EU | May 11, 2027 169 days |
| Grant | Improving biomass flows for a sustainable and circular bioeconomy European Commission · EU | Sep 22, 2027 303 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 136 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 303 days |
7 · Tech stack & innovations
- Chemoenzymatic Cascade Design in Soy and vegetable oil bio-printing inks:
- Coupled ketoreductase and transaminase cascades installing complex chiral centers with absolute stereochemical control (ee >99.8%).
- Computational retrosynthetic route truncation reducing total synthetic step count from 8 chemical stages to 3 biocatalytic operations.
- Microreactor Flow Chemistry & Extraction:
- Hastelloy continuous flow microchannels providing exceptional heat transfer rates (>10,000 W/m²·K) for exothermic biotransformations.
- Multi-stage counter-current centrifugal liquid-liquid extractors achieving complete product recovery with low solvent consumption.
- Continuous SMB Chromatography & Crystallization:
- Industrial simulated moving bed (SMB) chiral column trains resolving optical antipodes with solvent recovery exceeding 95%.
- Automated continuous oscillatory baffled crystallizers (COBC) utilizing inline FBRM probes to enforce metastable zone width control.
Sources 1 · 1 independent · 0 producer sites
Independent sources 1
- doi.org research checked 2026-11-15